CVB Financial Q1 EPS $0.36, net income $51.1M; NIM expands 13bps, loans shrink

CVB FINANCIAL CORP

2025-Q1 EPS reported $0.36

Diluted EPS $0.36 (flat QoQ); net income $51.1M vs $50.9M Q4'24 and $48.6M Q1'24.
Net interest margin 3.31% (+13bps QoQ); cost of funds fell to 1.04% from 1.13%.
Total loans down $172.8M QoQ; dairy & livestock loans dropped $167.8M (44%).
Nonperforming assets fell to $26.1M from $47.1M on sale of $19.3M OREO with $2.2M gain.
Repurchased 782,063 shares for $15.3M at avg $19.55; TCE ratio 10.0%.

item 2.02 item 9.01 item 8.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001193125-25-092125
form_type: 8-K
ticker: CVBF
cik: 0000354647
company_name: CVB FINANCIAL CORP
filed_at: 2025-04-24T23:59:59+00:00
discovered_at: 2026-05-14T18:02:50.950405+00:00
generated_at: 2026-05-23T07:27:39.410815+00:00
sec_items: ["2.02", "9.01", "8.01"]
event_type: earnings
sentiment: neutral
materiality_score: 0.6
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001193125-25-092125
json_url: https://secwatch.observer/filing/0001193125-25-092125.json
markdown_url: https://secwatch.observer/filing/0001193125-25-092125.md
text_url: https://secwatch.observer/filing/0001193125-25-092125.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/354647/000119312525092125/0001193125-25-092125-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/354647/000119312525092125/d892956d8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001193125-25-092125

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.